Company Profile

SINTX Technologies Inc (AKA: Amedica Corporation)
Profile last edited on: 2/28/2022      CAGE: 47W74      UEI: YPKAG52LF2S9

Business Identifier: Spinal and orthopedic implant and instruments utilizing proprietary silicon nitride technology
Year Founded
1996
First Award
1998
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1885 W 2100th South
Salt Lake City, UT 84119
   (801) 583-5100
   information@amedicacorp.com
   www.sintx.com
Location: Multiple
Congr. District: 02
County: Salt Lake

Public Profile

SINTX Technologies Inc (NASDAQ:SINT) formerly knowna sa Amedica Corporation (NASDAQ:AMDA), is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. Engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty. product revenue is defined as primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. The firm is however also defined as an OEM ceramics company developing and commercializing advanced ceramics for non-medical applications including armor. The Company presently manufactures silicon nitride materials and components in its FDA registered, ISO 13485:2016 certified, and ASD9100D certified manufacturing facility in Salt Lake City, Utah.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : SINT
IP Holdings
75-99

Awards Distribution by Agency

Key People / Management

  B Sonny Bal -- Chairman, President, Chief Executive Officer & CFO

  Eric Olson -- Chief Executive Officer, President & Director

  W Jose Belen -- Former President

  Ryan Bock

  Kevin Davis -- former Chief Operating Officer

  Eugene B Jones -- Vice President, Finance

  Ashok C Khandkar

  R Lakshminarayanan

  Brian J McEntire -- Chief Scientific Officer

  David Francis O'Brien -- Chief Operating Officer

  Cameron G Rouns -- Director

  Vytas Rupinskas -- Vice President, Marketing

  Chris Whitfield -- Chief Commercial Officer